Marta Palombo
Bologna, 40126, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
The cell-permeable iron chelator M606 inhibits MYCN-driven neuroblastoma via an E2F3-mediated response.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 02, 2025
Non-canonical activating roles of RCoR2 sustain transcription in adrenergic neuroblastoma.
Journal: Cell reports
Published: December 16, 2024
Synergistic Activity of Cefiderocol in Combination with Avibactam, Sulbactam or Tazobactam against Carbapenem-Resistant Gram-Negative Bacteria.
Journal: Cells
Published: June 06, 2024
Effect of incremental tazobactam concentrations on the bactericidal activity of piperacillin against ESBL-producing enterobacterales clinical isolates causing bacteraemia.
Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
Published: May 16, 2024
In vivo emergence of cefiderocol and ceftazidime/avibactam cross-resistance in KPC-producing Klebsiella pneumoniae following ceftazidime/avibactam -based therapies.
Journal: Diagnostic microbiology and infectious disease
Published: February 09, 2024
Molecular Mechanisms Underlying Loss of Vascular and Epithelial Integrity in Irritable Bowel Syndrome.
Journal: Gastroenterology
Published: December 22, 2023
In Vitro Evaluation of Increasing Avibactam Concentrations on Ceftazidime Activity against Ceftazidime/Avibactam-Susceptible and Resistant KPC-Producing Klebsiella pneumoniae Clinical Isolates.
Journal: Antibiotics (Basel, Switzerland)
Published: November 21, 2023
Clonal Dissemination of Candida auris Clinical Isolates in Northern Italy, 2021.
Journal: Microbial drug resistance (Larchmont, N.Y.)
Published: October 18, 2023
Synergistic Activity of Cefiderocol in Combination with Piperacillin-Tazobactam, Fosfomycin, Ampicillin-Sulbactam, Imipenem-Relebactam and Ceftazidime-Avibactam against Carbapenem-Resistant Gram-Negative Bacteria.
Journal: Antibiotics (Basel, Switzerland)
Published: April 05, 2023
Clonal dissemination of Klebsiella pneumoniae resistant to cefiderocol, ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam co-producing KPC and OXA-181 carbapenemase.
Journal: JAC-antimicrobial resistance
Published: March 16, 2023
New insights into irritable bowel syndrome pathophysiological mechanisms: contribution of epigenetics.
Journal: Journal of gastroenterology
Published: December 12, 2022
Last Updated: 09/26/2026